Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. No study details or user-facing content were changed.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI/text updates were made, including a glossary toggle, updated QC/posted timestamps, No FEAR Act labeling changes, and a revision note to v3.4.0. These are administrative changes and do not affect the study data or outcomes.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows Revision: v3.3.4; the previous Revision: v3.3.3 has been removed.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now includes a comprehensive list of trial locations, including U.S. states, Canadian provinces, and select international sites. This addition helps potential participants identify nearby enrollment centers and plan participation.SummaryDifference1%

- Check75 days agoChange DetectedAdded a new 'Last Update Posted (Estimated)' timestamp and removed the plain 'Last Update Posted' field in the Study Record Dates section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.